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Abstract
Genomic regulatory networks specify how cellular gene expression
responds to external temporal and spatial stimuli, ensuring that
correct cell fate decisions are made and the appropriate cell
phenotypes are adopted. In mammary epithelial cells, the hierarchy
of stem and progenitor cells and the genetically specified program
of transcriptional activity are beginning to be elucidated and
integrated. A novel role for Gata-3 in specifying and maintaining
mammary cell fate has recently been identified. These reports offer
an understanding of how mammary cells assume and maintain a
variety of cell behaviours and functions, and how a mammary cell
may potentially subvert these constraints during carcinogenesis.
Toward a combined understanding of cell
hierarchy and genomic regulatory networks
Genomic regulatory networks are composed of two principal
features, regulatory motifs (response elements, cis-regulatory
elements) and the genes that these motifs control. The
arrangement of regulatory motifs within gene promoters
provides a way to program the induction and repression of
gene expression in response to external signals. A key feature
is the use of cascading transcription factor networks to
control families of functional genes. An elegant demonstration
of a complete genomic regulatory network has been provided
for  Saccharomyces cerevisiae [1], while in mammals the
network responsive to oestrogen has been described using a
breast cancer cell line [2]. Given its developmental character-
istics, the mammary gland has emerged as a system in which
transcriptional networks and the extrinsic factors regulating
them can be investigated [3]. These networks are heritable,
both via the germline and also somatically. Thus, a cell’s
potential is specified, though not completely, by the cell that
produced it. It is clear that we have to combine these
fundamental aspects of inheritance and the genomic
regulatory network if we are to understand how external
stimuli, such as a hormonal change or cell context, can exert
the profound changes in gene expression and tissue
composition that we observe in the mammary gland.
Gata-3
The Gata family comprises six zinc-finger transcription factors
that have a well-defined role in cell-fate specification in the
immune system, kidney and other tissues. Constitutive null
mutation of Gata-3 results in embryonic lethality. In the
mammary gland Gata-3 is expressed only by the epithelium
and its expression increases during early pregnancy [4].
Recent work from Zena Werb’s laboratory [5] reports that
Gata-3 was the most highly enriched transcription factor in a
microarray analysis of terminal end-buds and ducts compared
to epithelium free stroma. Gata-3 expression can be detected
as early as E12.5 in primordial mammary buds of Gata-3/
LacZ knockin mice [6]. Expression in mammary epithelium
continues throughout puberty and pregnancy and Gata-3
expression is restricted to luminal cell lineages. The
expression and localisation of Gata-3 indicates a potential
role in the regulation of epithelial cell phenotype throughout
several stages of mammary gland development.
Gata-3 knockout
Using the Cre/lox system, both the Werb and Visvader labs
demonstrated a critical role for Gata-3 in the regulation of
several stages of mammopoiesis. Deletion of Gata-3 driven
by K14-Cre (expressed in mammary primordia) resulted in the
failure to form mammary placodes [6]. This finding is similar
to that observed following loss of the LEF1, Msx1 and Msx2
transcription factors [7] and may indicate a transcriptional
network or complex between these molecules.
Defects in ductal elongation and invasion through the
mammary fat pad were observed in both studies following
MMTV-Cre induced deletion of Gata-3 [5,6]. This phenotype
is similar to that observed following loss of oestrogen
receptor α. Interestingly, Gata-3 has previously been shown
to orchestrate transcriptional networks in other systems [8],
and it appears to have a similar function in the mammary
gland. Gata-3 binds to the promoter of FoxA1, a forkhead
factor that is required for chromatin binding of oestrogen
receptor [2,5]. This indicates a transcriptional network in
which Gata-3 regulates the transcriptional activity of
oestrogen receptor α, and identifies Gata-3 as a potential
master regulator of ductal elongation at puberty.
In addition to regulating mammary placode formation and
ductal elongation, a direct requirement for Gata-3 in epithelial
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cell differentiation was demonstrated. Deletion of Gata-3
following mammary ductal development resulted in failure of
the expansion of the luminal progenitor population required
for lobuloalveolar development during pregnancy [6]. This
finding was supported by the ability of Gata-3 expression to
drive a stem cell enriched population along the alveolar
luminal lineage. This is one of the first findings linking a
transcription factor to the enriched luminal cell progenitor
population it regulates. In this context it will be interesting to
determine which progenitor cell populations are acted upon
by other known transcriptional regulators of mammary
development such as Stat5 or C/EBPβ.
The failure of the luminal progenitor population expansion
following Gata-3 loss resulted in the accumulation of
undifferentiated luminal cells, characterised by an absence of
differentiation markers such as β casein [5,6]. The resulting
outcome was a failure of differentiation manifested as
impaired lactation. Several other knockout mice also display a
similar phenotype, most notably members of the prolactin
signalling pathway, such as Stat5 and Elf5, and molecules
that feed into this pathway or are markers of mammary stem
cells, such as β1 integrin. In prolactin receptor knockouts,
which also display a failure of lobuloalveolar development,
Gata-3 expression is greatly reduced [4,9]. Whether or not
Stat5, Elf5 or Gata-3 or others physically interact or are
members of the same transcriptional network remains to be
determined, as does their order in the cascade from hormonal
stimulus to execution of de novo transcription. Reduced
Gata-3 expression in prolactin receptor null mammary glands
may simply indicate the loss of Gata-3 cell populations in
these glands or, conversely, that Gata-3 is a true downstream
target of the prolactin pathway. What is clear, however, is
that although many transcription factors will prove essential
for this process, no one transcription factor is likely to act
alone. Rather, these transcription factors will act as part of a
coordinated transcriptional network, providing an integrated
response to multiple extracellular stimuli.
In addition to demonstrating that Gata-3 is a key regulator of
mammary gland development, the Werb and Visvader studies
also raise the interesting question of the role of Gata-3 in
breast cancer. Consistent with similar mammary gland
phenotypes and the link to FoxA1, expression of Gata-3
correlates with estrogen receptor-α in microarray studies of
human breast cancer [10]. High Gata-3 expression was a
marker for well-differentiated tumours, while low Gata-3
expression was strongly associated with markers of poor
patient prognosis, such as oestrogen receptor and
progesterone receptor negative status, high histological
grade and ErbB2 over-expression. The potential utility of
Gata-3 as a prognostic indicator has also been verified by
meta-analysis [11]. In addition, mutations in Gata-3 have
been reported in a subset of breast tumours, indicating a
potential tumour suppressor role [12]. These studies,
together with the Gata-3 regulatory role during mammary
gland development strongly support further studies into the
role of Gata-3 in human breast cancer.
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